Oviduct response to glucagon during hysterosalpingography.
Nine patients without evidence of tubal patency at routine hysterosalpingography were given glucagon. Five of the 9 responded with tubal dilation and spill. Three of the 4 who did not respond had a positive history and clinical examination for pelvic inflammatory disease. Data regarding side effects in the 9 patients studied are presented.
D005187:Fallopian Tubes / Q000187:drug effects*; D005260:Female; D005934:Glucagon / Q000494:pharmacology*; D006801:Humans; D007047:Hysterosalpingography; D013035:Spasm / Q000517:prevention & control
D005934:Glucagon